The company operates through two primary segments—Olefins & Derivatives (generating majority revenue) and Fertilizers & Methanol—serving downstream chemical applications across Asia. Facing earnings headwinds with negative EPS in 2024-2025, the company is currently valued at a P/B ratio of 0.72–0.73 (below 1.0), suggesting potential undervaluation amid fundamental volatility.
Cyborg Score Rationale
The company reported negative EPS in 2024 and 2025, indicating profitability challenges amid commodity price pressure and currency headwinds. However, strong market position and essential chemical product portfolio provide defensive characteristics. Current valuation offers potential upside for recovery-focused investors.
Top Insights
Negative EPS in 2024-2025 forces valuation shift to Price-to-Book metrics; P/B ratio of 0.72 suggests market values assets below book value
Q4 results expected to show wider net loss on weak product prices and forex pressures
Majority revenue derives from Malaysia, China, and Indonesia—critical regional market dependencies
Diversified product portfolio includes urea, ammonia, silicones, and lube oil additives providing revenue stability across end-markets
Named Competitors
BASF — Integrated global chemicals and materials manufacturer
Dow Inc. — Diversified petrochemical and advanced materials producer
Axiata Petronas — Parent company integrated oil and gas energy group